Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Pancreatic Neoplasms × Ifosfamide × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 7 Osteosarcoma 6 Lymphoma, Large B-Cell, Diffuse 6 Lymphoma 6 Testicular Neoplasms 4 Lymphoma, Non-Hodgkin 4 Testicular Germ Cell Tumor 3 Teratoma 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Lymphoma, B-Cell 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Breast Neoplasms 3 Wilms Tumor 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Ovarian Neoplasms 2 Optic Nerve Glioma 2 Neuroblastoma 2 Neoplasms 2 Medulloblastoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphatic Diseases 2 Liver Neoplasms 2 Kidney Neoplasms 2 Immunoproliferative Disorders 2 Hematologic Diseases 2 Fibrosarcoma 2 Familial ependymoma 2 Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Gemcitabine 86 130-nm albumin-bound paclitaxel 30 Oxaliplatin 27 Fluorouracil 24 Capecitabine 24 Leucovorin 19 Albumin-Bound Paclitaxel 19 Irinotecan 17 Erlotinib Hydrochloride 12 Cyclophosphamide 11 Bevacizumab 10 pembrolizumab 9 Radiotherapy 9 Radiosurgery 9 Nivolumab 9 Surgical Procedures, Operative 8 avelumab 6 Docetaxel 6 Cisplatin 6 ruxolitinib 5 folfirinox 5 Taxes 5 Paclitaxel 5 Everolimus 5 Cetuximab 5 ALT-803 5 spartalizumab 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Magnetic Resonance Spectroscopy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00967291 2012-02-01

PACT-11

IRCCS San Raffaele

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡